Conversely, loss of staining in tumours with wild‐type B2M might be due to large genomic rearrangements not identifiable with Sanger sequencing, promoter mutations, mutations involving miRNA recognition sites, low neoplastic cell content (<20%) or sampling error. Here, B2M is linked to neoplasm.